Jake Weeks

950 total citations
28 papers, 739 citations indexed

About

Jake Weeks is a scholar working on Pharmacology, Physiology and Biochemistry. According to data from OpenAlex, Jake Weeks has authored 28 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Physiology and 6 papers in Biochemistry. Recurrent topics in Jake Weeks's work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Jake Weeks is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Jake Weeks collaborates with scholars based in United States, Canada and United Kingdom. Jake Weeks's co-authors include John A. Jones, Donald W. DuCharme, Zalman Amit, Zavie W. Brown, John R. Schultz, Wendy Brown, William L. Miller, Barney J. Magerlein, A Robert and F.F. Sun and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Behavioral and Brain Sciences.

In The Last Decade

Jake Weeks

25 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jake Weeks United States 12 250 213 151 142 99 28 739
A. P. Caputi Italy 15 81 0.3× 257 1.2× 199 1.3× 55 0.4× 51 0.5× 29 903
Jane Telford United States 18 111 0.4× 293 1.4× 102 0.7× 160 1.1× 51 0.5× 46 739
Jerome H. Fleisch United States 18 141 0.6× 448 2.1× 520 3.4× 231 1.6× 164 1.7× 51 1.2k
Robinson Ds United Kingdom 14 106 0.4× 180 0.8× 208 1.4× 32 0.2× 94 0.9× 35 836
Silvano Sacco Italy 22 110 0.4× 263 1.2× 154 1.0× 100 0.7× 24 0.2× 43 1.1k
Nancy A. Sherman United States 12 87 0.3× 232 1.1× 180 1.2× 41 0.3× 72 0.7× 21 727
Donald O. Allen United States 19 54 0.2× 411 1.9× 274 1.8× 120 0.8× 62 0.6× 52 848
W. Lippmann United States 16 178 0.7× 222 1.0× 77 0.5× 204 1.4× 16 0.2× 71 719
Hiromasa Okada Japan 16 128 0.5× 437 2.1× 168 1.1× 109 0.8× 65 0.7× 45 1.4k
R. A. Fishman United States 17 95 0.4× 307 1.4× 190 1.3× 249 1.8× 22 0.2× 30 1.1k

Countries citing papers authored by Jake Weeks

Since Specialization
Citations

This map shows the geographic impact of Jake Weeks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Weeks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Weeks more than expected).

Fields of papers citing papers by Jake Weeks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Weeks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Weeks. The network helps show where Jake Weeks may publish in the future.

Co-authorship network of co-authors of Jake Weeks

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Weeks. A scholar is included among the top collaborators of Jake Weeks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Weeks. Jake Weeks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weeks, Jake, et al.. (2026). Imaging Evaluation for Steatotic Liver Disease. Korean Journal of Radiology. 27(2). 137–137.
2.
Howerton, Brock S., et al.. (2025). Receptor-Mediated SPION Labeling of CD4+ T Cells for Longitudinal MRI Tracking of Distribution Following Systemic Injection in Mouse. Nanomaterials. 15(14). 1068–1068. 2 indexed citations
3.
Zifan, Ali, Kai Zhao, Jake Weeks, et al.. (2025). Adaptive Evolutionary Optimization of Deep Learning Architectures for Focused Liver Ultrasound Image Segmentation. Diagnostics. 15(2). 117–117.
4.
Weeks, Jake, Michael P. André, Eduardo Grunvald, et al.. (2024). Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults. Ultrasound in Medicine & Biology. 51(3). 475–483.
5.
Wolfson, Tanya, Jake Weeks, Cynthia Behling, et al.. (2024). MASLD: What We Have Learned and Where We Need to Go—A Call to Action. Radiographics. 44(11). e240048–e240048. 12 indexed citations
6.
Amit, Zalman, et al.. (1980). A simple double channel swivel for infusions of fluids into unrestrained animals. Pharmacology Biochemistry and Behavior. 12(3). 463–466. 18 indexed citations
7.
Morozowich, W., et al.. (1979). Prostaglandin Prodrugs III: Synthesis and Biological Properties of C9- and C15CIS-Monoesters of Dinoprost (Prostaglandin F2α). Journal of Pharmaceutical Sciences. 68(8). 949–951. 3 indexed citations
8.
Morozowich, W., et al.. (1979). Prostaglandin prodrugs I: Stabilization of dinoprostone (prostaglandin E2) in solid state through formation of crystalline C1-phenyl esters. Journal of Pharmaceutical Sciences. 68(7). 833–836. 10 indexed citations
9.
Weeks, Jake. (1978). The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.. PubMed. 37(5-6). 707–14. 1 indexed citations
10.
Weeks, Jake. (1978). The general pharmacology of prostacyclin (pgi2, pgx): a new prostaglandin especially activity on the cardiovascular system.. PubMed. 30(2-3). 215–21. 8 indexed citations
11.
Brown, Zavie W., Zalman Amit, & Jake Weeks. (1976). Simple flow-thru swivel for infusions into unrestrained animals. Pharmacology Biochemistry and Behavior. 5(3). 363–365. 92 indexed citations
12.
Magerlein, Barney J., Donald W. DuCharme, Wayne E. Magee, et al.. (1973). Synthesis and biological properties of 16-alkylprostaglandins. Prostaglandins. 4(1). 143–145. 49 indexed citations
13.
Weeks, Jake. (1972). Prostaglandins. Annual Review of Pharmacology. 12(1). 317–336. 93 indexed citations
14.
Weeks, Jake, et al.. (1969). Relative activity of prostaglandins E1, A1, E2 and A2 on lipolysis, platelet aggregation, smooth muscle and the cardiovascular system. Journal of Pharmacy and Pharmacology. 21(2). 103–108. 47 indexed citations
15.
Weeks, Jake, et al.. (1968). Pharmacological profile of a new prostaglandin 8 iso prostaglandin e 1. 10(2). 212. 4 indexed citations
16.
DuCharme, Donald W., et al.. (1968). STUDIES ON THE MECHANISM OF THE HYPERTENSIVE EFFECT OF PROSTAGLANDIN F2α. Journal of Pharmacology and Experimental Therapeutics. 160(1). 1–10. 21 indexed citations
17.
Schultz, John R., et al.. (1968). Evaluation and control of variability in hormone-stimulated lipolysis in rat adipose tissue. Journal of Pharmacy and Pharmacology. 20(5). 400–402. 2 indexed citations
18.
DuCharme, Donald W., et al.. (1968). Studies on the mechanism of the hypertensive effect of prostaglandin F2-alpha.. PubMed. 160(1). 1–10. 94 indexed citations
19.
Weeks, Jake, John R. Schultz, & Wendy Brown. (1968). Evaluation of smooth muscle bioassays for prostaglandins E 1 and F 1 alpha. Journal of Applied Physiology. 25(6). 783–785. 41 indexed citations
20.
Weeks, Jake. (1963). Physiological Techniques in Pharmacology. Annual Review of Pharmacology. 3(1). 335–342. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026